Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Capital Expenditures (2021 - 2025)

Oncology Institute's Capital Expenditures history spans 5 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 39.6% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $3.2 million, down 15.54%, while the annual FY2025 figure was $3.2 million, 15.54% down from the prior year.
  • Capital Expenditures reached $1.1 million in Q4 2025 per TOI's latest filing, up from $604000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q4 2022 to a low of -$402000.0 in Q3 2024.
  • Average Capital Expenditures over 5 years is $996600.0, with a median of $943500.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: crashed 143.23% in 2024, then surged 250.25% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $871000.0 in 2021, then soared by 129.05% to $2.0 million in 2022, then tumbled by 56.84% to $861000.0 in 2023, then soared by 103.83% to $1.8 million in 2024, then tumbled by 39.6% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Capital Expenditures are $1.1 million (Q4 2025), $604000.0 (Q3 2025), and $1.2 million (Q2 2025).